Page 22 - Translational Sciences News Today

A new category of depression, the cognitive biotype, accounts for 27% of depressed patients, say researchers.

Using surveys, cognitive tests and brain imaging, researchers have identified a type of depression that affects about a quarter of patients. The goal is to diagnose and treat the condition more precisely.

This time next week, the Boston Convention and Exhibition Center will be positively buzzing with a broad range of those in the pharmaceutical industry for the annual DIA global meeting.

Postural Orthostatic Tachycardia Syndrome (POTS) is a circulatory disorder which is characterized by an increase in heart rate or tachycardia and is treated by medicines, diet, exercise and lifestyle changes.

Anencephaly is a neural tube defect (NTD), in which a baby is born with an underdeveloped brain and skull. Major portions of the brain may be missing or completely absent. Sadly, there is no treatment for this condition.

Using 3-D models of ovarian cancer tumors, scientists found differences in gene activity based on where a cell is in a tumor, demonstrating how a cell's location and environment in a cancerous tumor can strongly influence which genes are active and the cell's role in the cancer's biology.

Scientists at Stanford Medicine conducted a study describing a new category of depression -; labeled the cognitive biotype -; which accounts for 27% of depressed patients and is not effectively treated by commonly prescribed antidepressants.

Researchers discovered a new depression subtype, the 'cognitive biotype,' affecting 27% of patients who respond poorly to typically prescribed antidepressants.

Introducing widespread screening of newborns for a deadly disease called severe combined immunodeficiency, or SCID, followed by early treatment boosted the five-year survival rate of children with the disorder from 73% before the advent of screening to 87% since, researchers report.

News and events briefs